Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE
<p>Abstract</p> <p>Background</p> <p>The CC chemokine receptors CCR1, CCR2 and CCR5 are critical for the recruitment of mononuclear phagocytes to the central nervous system (CNS) in multiple sclerosis (MS) and other neuroinflammatory diseases. Mononuclear phagocytes are...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-05-01
|
Series: | Journal of Neuroinflammation |
Online Access: | http://www.jneuroinflammation.com/content/4/1/14 |
id |
doaj-30c3a816252544e89a8a034416eb3ebb |
---|---|
record_format |
Article |
spelling |
doaj-30c3a816252544e89a8a034416eb3ebb2020-11-24T23:30:59ZengBMCJournal of Neuroinflammation1742-20942007-05-01411410.1186/1742-2094-4-14Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAEEricsson-Dahlstrand AndersOlsson TomasNilsson MariaWallström ErikLassmann HansBerg Anna-LenaEltayeb SanaSunnemark Dan<p>Abstract</p> <p>Background</p> <p>The CC chemokine receptors CCR1, CCR2 and CCR5 are critical for the recruitment of mononuclear phagocytes to the central nervous system (CNS) in multiple sclerosis (MS) and other neuroinflammatory diseases. Mononuclear phagocytes are effector cells capable of phagocytosing myelin and damaging axons. In this study, we characterize the regional, temporal and cellular expression of CCR1, CCR2 and CCR5 mRNA in the spinal cord of rats with myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-EAE). While resembling human MS, this animal model allows unique access to CNS-tissue from various time-points of relapsing neuroinflammation and from various lesional stages: early active, late active, and inactive completely demyelinated lesions.</p> <p>Methods</p> <p>The expression of CCR1, CCR2 and CCR5 mRNA was studied with <it>in situ </it>hybridization using radio labelled cRNA probes in combination with immunohistochemical staining for phenotypic cell markers. Spinal cord sections from healthy rats and rats with MOG-EAE (acute phase, remission phase, relapse phase) were analysed. In defined lesion stages, the number of cells expressing CCR1, CCR2 and CCR5 mRNA was determined. Data were statistically analysed by the nonparametric Mann-Whitney U test.</p> <p>Results</p> <p>In MOG-EAE rats, extensive up-regulation of CCR1 and CCR5 mRNA, and moderate up-regulation of CCR2 mRNA, was found in the spinal cord during episodes of active inflammation and demyelination. Double staining with phenotypic cell markers identified the chemokine receptor mRNA-expressing cells as macrophages/microglia. Expression of all three receptors was substantially reduced during clinical remission, coinciding with diminished inflammation and demyelination in the spinal cord. Healthy control rats did not show any detectable expression of CCR1, CCR2 or CCR5 mRNA in the spinal cord.</p> <p>Conclusion</p> <p>Our results demonstrate that the acute and chronic-relapsing phases of MOG-EAE are associated with distinct expression of CCR1, CCR2, and CCR5 mRNA by cells of the macrophage/microglia lineage within the CNS lesions. These data support the notion that CCR1, CCR2 and CCR5 mediate recruitment of both infiltrating macrophages and resident microglia to sites of CNS inflammation. Detailed knowledge of expression patterns is crucial for the understanding of therapeutic modulation and the validation of CCR1, CCR2 and CCR5 as feasible targets for therapeutic intervention in MS.</p> http://www.jneuroinflammation.com/content/4/1/14 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ericsson-Dahlstrand Anders Olsson Tomas Nilsson Maria Wallström Erik Lassmann Hans Berg Anna-Lena Eltayeb Sana Sunnemark Dan |
spellingShingle |
Ericsson-Dahlstrand Anders Olsson Tomas Nilsson Maria Wallström Erik Lassmann Hans Berg Anna-Lena Eltayeb Sana Sunnemark Dan Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE Journal of Neuroinflammation |
author_facet |
Ericsson-Dahlstrand Anders Olsson Tomas Nilsson Maria Wallström Erik Lassmann Hans Berg Anna-Lena Eltayeb Sana Sunnemark Dan |
author_sort |
Ericsson-Dahlstrand Anders |
title |
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE |
title_short |
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE |
title_full |
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE |
title_fullStr |
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE |
title_full_unstemmed |
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE |
title_sort |
temporal expression and cellular origin of cc chemokine receptors ccr1, ccr2 and ccr5 in the central nervous system: insight into mechanisms of mog-induced eae |
publisher |
BMC |
series |
Journal of Neuroinflammation |
issn |
1742-2094 |
publishDate |
2007-05-01 |
description |
<p>Abstract</p> <p>Background</p> <p>The CC chemokine receptors CCR1, CCR2 and CCR5 are critical for the recruitment of mononuclear phagocytes to the central nervous system (CNS) in multiple sclerosis (MS) and other neuroinflammatory diseases. Mononuclear phagocytes are effector cells capable of phagocytosing myelin and damaging axons. In this study, we characterize the regional, temporal and cellular expression of CCR1, CCR2 and CCR5 mRNA in the spinal cord of rats with myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis (MOG-EAE). While resembling human MS, this animal model allows unique access to CNS-tissue from various time-points of relapsing neuroinflammation and from various lesional stages: early active, late active, and inactive completely demyelinated lesions.</p> <p>Methods</p> <p>The expression of CCR1, CCR2 and CCR5 mRNA was studied with <it>in situ </it>hybridization using radio labelled cRNA probes in combination with immunohistochemical staining for phenotypic cell markers. Spinal cord sections from healthy rats and rats with MOG-EAE (acute phase, remission phase, relapse phase) were analysed. In defined lesion stages, the number of cells expressing CCR1, CCR2 and CCR5 mRNA was determined. Data were statistically analysed by the nonparametric Mann-Whitney U test.</p> <p>Results</p> <p>In MOG-EAE rats, extensive up-regulation of CCR1 and CCR5 mRNA, and moderate up-regulation of CCR2 mRNA, was found in the spinal cord during episodes of active inflammation and demyelination. Double staining with phenotypic cell markers identified the chemokine receptor mRNA-expressing cells as macrophages/microglia. Expression of all three receptors was substantially reduced during clinical remission, coinciding with diminished inflammation and demyelination in the spinal cord. Healthy control rats did not show any detectable expression of CCR1, CCR2 or CCR5 mRNA in the spinal cord.</p> <p>Conclusion</p> <p>Our results demonstrate that the acute and chronic-relapsing phases of MOG-EAE are associated with distinct expression of CCR1, CCR2, and CCR5 mRNA by cells of the macrophage/microglia lineage within the CNS lesions. These data support the notion that CCR1, CCR2 and CCR5 mediate recruitment of both infiltrating macrophages and resident microglia to sites of CNS inflammation. Detailed knowledge of expression patterns is crucial for the understanding of therapeutic modulation and the validation of CCR1, CCR2 and CCR5 as feasible targets for therapeutic intervention in MS.</p> |
url |
http://www.jneuroinflammation.com/content/4/1/14 |
work_keys_str_mv |
AT ericssondahlstrandanders temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae AT olssontomas temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae AT nilssonmaria temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae AT wallstromerik temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae AT lassmannhans temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae AT bergannalena temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae AT eltayebsana temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae AT sunnemarkdan temporalexpressionandcellularoriginofccchemokinereceptorsccr1ccr2andccr5inthecentralnervoussysteminsightintomechanismsofmoginducedeae |
_version_ |
1725539341843824640 |